Human clinical data showed high-CBD cannabis increased anti-inflammatory lipid mediators, particularly lipoxins, while high-THC cannabis did not produce the same effect.
Inflammation researchers, medical cannabis prescribers, CBD product developers
CBD increased anti-inflammatory lipoxins in humans; THC did not
What the researchers found
Using plasma data from multiple clinical studies, high-CBD cannabis use led to increased levels of anti-inflammatory eicosanoids, particularly lipoxins produced through the 15-LOX pathway. High-THC cannabis did not produce similar increases in these anti-inflammatory mediators.
Why it matters
This is rare human-level evidence showing how CBD produces anti-inflammatory effects at the molecular level, specifically through lipid mediator pathways, supporting its therapeutic potential for inflammatory diseases.
The numbers in context
High-CBD cannabis increased lipoxin levels via the 15-LOX pathway. High-THC cannabis showed no similar increase. Eicosanoid levels measured across LOX, COX, and CYP450 pathways.
How the study worked
Analysis of plasma samples from multiple clinical studies comparing the effects of high-CBD versus high-THC cannabis on eicosanoid levels generated through LOX, COX, and CYP450 pathways.
What this study cannot tell us
Pooled data from multiple studies introduces variability. Cannot control for all differences between study populations. Specific CBD and THC doses varied. Plasma levels may not reflect tissue-level effects.
How to read the evidence
Human plasma data from clinical studies, but pooled design introduces variability.
When this study was published
2025 analysis of human clinical trial plasma samples.
The bigger picture
Most CBD anti-inflammatory evidence comes from cell and animal studies. This human data identifies the specific lipid mediator pathway through which CBD works, providing a mechanistic foundation for clinical applications.
Questions still open
- What CBD dose maximizes lipoxin production? Could CBD replace NSAIDs for inflammation? Does the 15-LOX pathway explain CBD benefits in specific inflammatory diseases?
Common questions
How does CBD reduce inflammation?
Is THC anti-inflammatory too?
Read the original research
Effect of Cannabidiol and Δ9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans.
Cannabis and cannabinoid research, 10(4), 506-511
Citation
Morris, Alan W J; Mueller, Raeghan L; Sempio, Cristina; Klawitter, Jost; Bryan, Angela D; Bidwell, L Cinnamon; Hutchison, Kent E. (2025). Effect of Cannabidiol and Δ9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans.. Cannabis and cannabinoid research, 10(4), 506-511. https://doi.org/10.1089/can.2024.0175
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk